FDA Investigator: Matthew B. Casale

- Matthew B. Casale first started conducting FDA inspections in 2002, with the last inspection in 2024. Over that time, Matthew B. Casale has conducted 388 inspections at 322 companies across 352 sites.

Documents

FDA 483 Steri-Med Pharma Inc., Upton | 2024

Out-of-stock
Matthew B. Casale
Human Drugs Form 483

FDA 483 Ash Stevens LLC, Riverview | 2024

Out-of-stock
Matthew B. Casale
Human Drugs Form 483

FDA 483 Qilu Pharmaceutical Co., Ltd. (Dongjia Site), Jinan | 2023

Out-of-stock
Matthew B. Casale
Human Drugs Form 483

FDA 483 Qilu Pharmaceutical Co., Ltd., Jinan | 2023

Out-of-stock
Matthew B. Casale
Human Drugs Form 483

FDA 483 Corden Pharma Fribourg SA, Villars-Sur-Glane | 2023

Out-of-stock
Matthew B. Casale
Human Drugs Form 483

FDA 483 Savior Lifetec Corporation, Tainan City | 2022

Out-of-stock
Matthew B. Casale
Human Drugs Form 483

FDA 483 Alembic Pharmaceuticals Limited, Karkhadi | 2022

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Amneal Injectables Private Limited, Palli | 2022

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 AqVida GmbH, Dassow | 2022

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 DMB Apparatebau GmbH, Worrstadt | 2022

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Ricola Ag, Laufen | 2022

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Maropack AG, Zell Lu | 2022

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Samsung Biologics Co., Ltd., Incheon | 2019

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Celltrion Inc., Yeonsu | 2019

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Rubicon Research Private Limited, Ambernath | 2019

Out-of-stock
Matthew B. Casale
Human Drug Form 483

FDA 483 Hot Shots Nuclear Medicine, Davenport | 2019

Out-of-stock
Matthew B. Casale
Human Drug Form 483

Co-Investigators (58)